Glucopyranose group derivative compound, preparation method and applications

The invention relates to a compound formed by a glucopyranose group derivative and L-pyroglutamic acid as a sodium-independent glucose transporter inhibitor, a preparation method of the compound, a pharmaceutical composition containing the compound, and applications of the compound and the pharmaceu...

Full description

Saved in:
Bibliographic Details
Main Authors KANG PANPAN, DENG BINGCHU, WU WUYONG, ZHANG ZONGYUAN, GU ZHENG, QU TONG
Format Patent
LanguageChinese
English
Published 09.06.2017
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a compound formed by a glucopyranose group derivative and L-pyroglutamic acid as a sodium-independent glucose transporter inhibitor, a preparation method of the compound, a pharmaceutical composition containing the compound, and applications of the compound and the pharmaceutical composition in treatment of diabetes mellitus and/or diabetes mellitus-related diseases. 本发明涉及种作为钠依赖性葡萄糖转运蛋白(SGLT)抑制剂的吡喃葡萄糖基衍生物和L-焦谷氨酸形成的复合物、该复合物的制备方法及含有该复合物的药物组合物和它们用于制备治疗糖尿病和/或糖尿病相关疾病的用途。
Bibliography:Application Number: CN201611070532